Topic

Articles

In this Q&A, John Kastelein, MD, founder and chief scientific officer, NewAmsterdam Pharma, discusses the challenges and opportunities within the cardiovascular field, exploring the current landscape for lipid-lowering therapies and the unique potential advantages of CETP inhibitors. 

Breaking New Ground in Cardiovascular Health: Innovative Approaches in Clinical Trial Design

Clinical Vice President, Internal Medicine, Signant Health

Examining the two areas of weakness cited in FDA draft guidance.

Optimal COA Measurement Strategy in Modern Oncology Trials

Senior Director, Therapeutic Strategy Lead, Rare Disease, Worldwide Clinical Trials

Stakeholders must alter their mindsets when it comes to early-phase design and interpreting regulatory guidance for CGT trials.

Evolving Tools and Perspectives for the Development of Cell and Gene Therapies

Increased data output from the use of devices can accelerate trials for this therapeutic area in need of new therapies. 

Breathing New Life into Respiratory Clinical Trials with Digital Biomarkers

Webcasts

Webinar Date/Time:
Thursday, May 25th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Precision Medicine in Clinical Trials: Adapting to the New Demands of Clinical Research Today

Associate Director, Clinical Pharmacology, Certara

Director, Clinical Pharmacology and Translational Medicine, Certara

January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

Tiffany Chow, MD, a specialist in behavioral neurology and senior medical director at Alector, discusses the unique challenges of designing clinical trials for frontotemporal dementia.

Designing Clinical Trials for Frontotemporal Dementia

Leal Health Poster Highlights Negative Impact of Patient ECOG Scores on Clinical Trial Enrollment Eligibility at 2023 ASCO GU Cancers Symposium. 




Are ECOG Scores Restricting Patient Access to Clinical Trials?

Webinar Date/Time: Tue, Mar 28, 2023 11:00 AM EDT

The Silent Pandemic: Antimicrobial Resistance

Sanjay Shukla, MD, MS, CEO of aTyr Pharma, discusses the company's clinical operations and ongoing Phase III study for pulmonary sarcoidosis.

Therapeutic Areas